UBS Group’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$162 Sell
34
-3,380
-99% -$16.1K ﹤0.01% 8624
2025
Q1
$19.6K Buy
3,414
+259
+8% +$1.48K ﹤0.01% 6952
2024
Q4
$21.9K Buy
3,155
+3,121
+9,179% +$21.7K ﹤0.01% 6581
2024
Q3
$193 Hold
34
﹤0.01% 7864
2024
Q2
$241 Sell
34
-2,141
-98% -$15.2K ﹤0.01% 7879
2024
Q1
$17.3K Buy
2,175
+1,479
+213% +$11.8K ﹤0.01% 5818
2023
Q4
$4.87K Buy
696
+551
+380% +$3.86K ﹤0.01% 6608
2023
Q3
$1.29K Buy
145
+123
+559% +$1.1K ﹤0.01% 6851
2023
Q2
$321 Sell
22
-1,896
-99% -$27.7K ﹤0.01% 7224
2023
Q1
$28.9K Buy
1,918
+1,608
+519% +$24.2K ﹤0.01% 5737
2022
Q4
$11.8K Sell
310
-1,153
-79% -$44K ﹤0.01% 7159
2022
Q3
$15K Buy
1,463
+205
+16% +$2.1K ﹤0.01% 6709
2022
Q2
$19K Buy
1,258
+894
+246% +$13.5K ﹤0.01% 5906
2022
Q1
$25K Sell
364
-331
-48% -$22.7K ﹤0.01% 6154
2021
Q4
$42K Buy
695
+502
+260% +$30.3K ﹤0.01% 5969
2021
Q3
$25K Sell
193
-6,715
-97% -$870K ﹤0.01% 5789
2021
Q2
$1.83M Buy
6,908
+5,762
+503% +$1.52M ﹤0.01% 2803
2021
Q1
$386K Buy
1,146
+1,026
+855% +$346K ﹤0.01% 4111
2020
Q4
$40K Buy
120
+72
+150% +$24K ﹤0.01% 5386
2020
Q3
$18K Sell
48
-226
-82% -$84.8K ﹤0.01% 5521
2020
Q2
$144K Sell
274
-57
-17% -$30K ﹤0.01% 4228
2020
Q1
$145K Sell
331
-313
-49% -$137K ﹤0.01% 4127
2019
Q4
$119K Buy
644
+365
+131% +$67.4K ﹤0.01% 4885
2019
Q3
$53K Buy
279
+181
+185% +$34.4K ﹤0.01% 5226
2019
Q2
$31K Buy
98
+60
+158% +$19K ﹤0.01% 5437
2019
Q1
$16K Sell
38
-38
-50% -$16K ﹤0.01% 5652
2018
Q4
$19K Buy
76
+66
+660% +$16.5K ﹤0.01% 5907
2018
Q3
$5K Hold
10
﹤0.01% 6568
2018
Q2
$7K Sell
10
-16
-62% -$11.2K ﹤0.01% 6408
2018
Q1
$21K Buy
+26
New +$21K ﹤0.01% 5509
2017
Q4
Sell
-47
Closed -$54K 6908
2017
Q3
$54K Buy
+47
New +$54K ﹤0.01% 4859